NC
HALO icon

nVerses Capital’s Halozyme HALO Stock Holding History

nVerses Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
+3,058
New +$209K 0.37% 122
2024
Q3 		– Sell
-4,700
Closed -$246K – 1162
2024
Q2 		$246K Buy
4,700
+2,900
+161% +$127K 0.15% 226
2024
Q1 		$73.2K Buy
+1,800
New +$67.5K 0.18% 217

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

nVerses Capital's HALO Position: Q2 2026 in Review

nVerses Capital opened a new position in Halozyme (HALO) in Q2 2026: 3,058 shares worth $239K. The stake represents 0.37% of the portfolio and ranks #122 among its holdings. This is a return to the name: nVerses Capital previously reported a position in HALO as recently as Q2 2024.

nVerses Capital first reported a position in HALO in Q1 2024 and has held it in 3 quarters since. The position peaked at $246K in Q2 2024. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • nVerses Capital held 3,058 shares of Halozyme worth $239K as of Q2 2026.
  • Halozyme was a new nVerses Capital position in Q2 2026.
  • Halozyme made up 0.37% of nVerses Capital's portfolio in Q2 2026, its #122 holding.
  • nVerses Capital first reported a position in Halozyme in Q1 2024 and has held it in 3 quarters since.
  • nVerses Capital's Halozyme position peaked at $246K in Q2 2024.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.